Controversial Dengue Drug Among Six Products To Get EMA Thumbs Up

 
• By Neena Brizmohun

Dengvaxia, the dengue vaccine from Sanofi that was suspended in the Philippines last year, is among six new products to get a recommendation for marketing authorization from the European Medicines Agency this week.

Pills
New drugs have received recommendations for EU approval • Source: Shutterstock

More from Approvals

More from Product Reviews